Onur İsmi1, Cengiz Özcan1, Tuba Karabacak2, Gürbüz Polat3, Yusuf Vayisoğlu1, Taylan Güçlütürk4, Kemal Görür1. 1. Department of Otorhinolaryngology, Mersin University Faculty of Medicine, Mersin, Turkey. 2. Department of Pathology, Mersin University Faculty of Medicine, Mersin, Turkey. 3. Department of Medical Biochemistry, Mersin University Faculty of Medicine, Mersin, Turkey. 4. Department of Otorhinolaryngology, Gaziantep State Hospital, Gaziantep, Turkey.
Abstract
BACKGROUND: Allergic rhinitis is a common inflammatory nasal mucosal disease characterized by sneezing, watery nasal discharge, nasal obstruction and itching. Although allergen-specific antibodies play a main role in the allergic airway inflammation, neuronal inflammation may also contribute to the symptoms of allergic rhinitis. Neuronal inflammation is primarily caused by the stimulation of sensory nerve endings with histamine. It has been shown that neurotrophins may also have a role in allergic reactions and neuronal inflammation. Nerve growth factor, neurotrophin 3 (NT-3), neurotrophin 4/5 and brain-derived neurotrophic factor are members of the neurotrophin family. Although nerve growth factor and brain-derived neurotrophic factor are well studied in allergic rhinitis patients, the exact role of Neurotrophin-3 is not known. AIMS: To investigate the possible roles of neurotrophin-3 in allergic rhinitis patients. STUDY DESIGN: Case-control study. METHODS: Neurotrophin-3 levels were studied in the inferior turbinate and serum samples of 20 allergic rhinitis and 13 control patients. Neurotrophin-3 staining of nasal tissues was evaluated by immunohistochemistry and ELISA was used for the determination of serum Neurotrophin-3 levels. RESULTS: Neurotrophin-3 staining scores were statistically higher in the study group than in the control patients (p=0.001). Regarding serum Neurotrophin-3 levels, no statistically significant difference could be determined between allergic rhinitis and control patients (p=0.156). When comparing the serum NT-3 levels with tissue staining scores, there were no statistically significant differences in the allergic rhinitis and control groups (p=0.254 for allergic rhinitis and p=0.624 for control groups). CONCLUSION: We suggest that Neurotrophin-3 might affect the nasal mucosa locally without being released into the systemic circulation in allergic rhinitis patients.
BACKGROUND:Allergic rhinitis is a common inflammatory nasal mucosal disease characterized by sneezing, watery nasal discharge, nasal obstruction and itching. Although allergen-specific antibodies play a main role in the allergic airway inflammation, neuronal inflammation may also contribute to the symptoms of allergic rhinitis. Neuronal inflammation is primarily caused by the stimulation of sensory nerve endings with histamine. It has been shown that neurotrophins may also have a role in allergic reactions and neuronal inflammation. Nerve growth factor, neurotrophin 3 (NT-3), neurotrophin 4/5 and brain-derived neurotrophic factor are members of the neurotrophin family. Although nerve growth factor and brain-derived neurotrophic factor are well studied in allergic rhinitispatients, the exact role of Neurotrophin-3 is not known. AIMS: To investigate the possible roles of neurotrophin-3 in allergic rhinitispatients. STUDY DESIGN: Case-control study. METHODS:Neurotrophin-3 levels were studied in the inferior turbinate and serum samples of 20 allergic rhinitis and 13 control patients. Neurotrophin-3 staining of nasal tissues was evaluated by immunohistochemistry and ELISA was used for the determination of serum Neurotrophin-3 levels. RESULTS:Neurotrophin-3 staining scores were statistically higher in the study group than in the control patients (p=0.001). Regarding serum Neurotrophin-3 levels, no statistically significant difference could be determined between allergic rhinitis and control patients (p=0.156). When comparing the serum NT-3 levels with tissue staining scores, there were no statistically significant differences in the allergic rhinitis and control groups (p=0.254 for allergic rhinitis and p=0.624 for control groups). CONCLUSION: We suggest that Neurotrophin-3 might affect the nasal mucosa locally without being released into the systemic circulation in allergic rhinitispatients.
Authors: Charlotta Dagnell; Cecilia Kemi; Julius Klominek; Per Eriksson; C Magnus Sköld; Anders Eklund; Johan Grunewald; Caroline Olgart Höglund Journal: Transl Res Date: 2007-05-29 Impact factor: 7.012
Authors: Melanie Abram; Michael Wegmann; Verena Fokuhl; Sanchaita Sonar; Elke Olga Luger; Sebastian Kerzel; Andreas Radbruch; Harald Renz; Michael Zemlin Journal: J Immunol Date: 2009-04-15 Impact factor: 5.422
Authors: Paulina Sobkowiak; Wojciech Langwiński; Joanna Nowakowska; Irena Wojsyk-Banaszak; Dawid Szczepankiewicz; Dorota Jenerowicz; Eliza Wasilewska; Anna Bręborowicz; Aleksandra Szczepankiewicz Journal: Biomed Res Int Date: 2020-06-10 Impact factor: 3.411
Authors: Cengiz Ozcan; Onur Ismi; Tuba Kara; Gurbuz Polat; Osman Erdogan; Senay Balci Fidanci; Yusuf Vayisoglu; Kemal Gorur Journal: Medeni Med J Date: 2020-02-28